/ Side by side
Melanotan II vs Afamelanotide
A neutral, side-by-side look at Melanotan II and Afamelanotide: what each one is, its class, half-life, storage, and the public sources behind it. Educational reference only, not medical advice, dosing, or a recommendation to use either compound.
Melanotan II
MT-2 · MT2
Full profile →Afamelanotide
Scenesse · Melanotan-1 · Melanotan I
Full profile →| Attribute | Melanotan II | Afamelanotide |
|---|---|---|
| Category | Sexual / Hormonal | Sexual / Hormonal |
| Half-life | ~1 h, subcutaneous | ~15 h, controlled-release subcutaneous implant |
| Common vial | 10 mg | 16 mg |
| Reference | Verified | Verified |
What is Melanotan II?
A synthetic cyclic analog of alpha-melanocyte-stimulating hormone acting as a non-selective melanocortin receptor agonist. Studied in relation to skin pigmentation and, via MC4R activation, sexual arousal. Not FDA-approved.
Sources
- ScienceDirect Topics: Melanotan II
- Peer-reviewed melanocortin pharmacology
What is Afamelanotide?
A melanocortin-1 receptor agonist approved to increase pain-free light exposure in adults with erythropoietic protoporphyria, a rare photosensitivity disorder. It is delivered as a controlled-release implant. Its approved use is photoprotection, not weight, performance or sexual function.
Sources
- FDA label: SCENESSE (NDA 210797)
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.